Based on the below from the AR it looks like they are thinking ahead in relation to NNZ-2591 partnership. Its a bullish statement. I wonder if they are in discussions with any parties at the moment as i recall Jon did mention they had interest.
NNZ-2591 has the potential to generate larger value for shareholders than trofinetide. We are now carefully evaluating all options to maximize this value, preparing actively for Phase 3 studies while remaining receptive to partnering alternatives.
Add to My Watchlist
What is My Watchlist?
